These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20024753)

  • 21. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV Epidemiology Research study: on-site versus referral care.
    Rompalo AM; Shah N; Mayer K; Schuman P; Klein RS; Smith DK; Vlahov D
    J Acquir Immune Defic Syndr; 2001 Sep; 28(1):28-34. PubMed ID: 11579274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
    Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
    HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users.
    Palepu A; Milloy MJ; Kerr T; Zhang R; Wood E
    J Urban Health; 2011 Jun; 88(3):545-55. PubMed ID: 21409604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users.
    Altice FL; Springer S; Buitrago M; Hunt DP; Friedland GH
    J Urban Health; 2003 Sep; 80(3):416-27. PubMed ID: 12930880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.
    Mullen BA; Cook K; Moore RD; Rand C; Galai N; McCaul ME; Glass S; Oursler KK; Lucas GM
    BMC Infect Dis; 2011 Feb; 11():45. PubMed ID: 21324133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the association between Addiction Severity Index and depression with adherence to anti-retroviral therapy among HIV infected patients.
    Paydary K; Ekhtiari H; Noori M; Rad MV; Hajiabdolbaghi M; SeyedAlinaghi S
    Infect Disord Drug Targets; 2015; 15(3):177-83. PubMed ID: 26411558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trust and the acceptance of and adherence to antiretroviral therapy.
    Altice FL; Mostashari F; Friedland GH
    J Acquir Immune Defic Syndr; 2001 Sep; 28(1):47-58. PubMed ID: 11579277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda.
    Nakasujja N; Vecchio AC; Saylor D; Lofgren S; Nakigozi G; Boulware DR; Kisakye A; Batte J; Mayanja R; Anok A; Reynolds SJ; Quinn TC; Pardo CA; Kumar A; Gray RH; Wawer MJ; Sacktor N; Rubin LH
    J Neurovirol; 2021 Aug; 27(4):519-530. PubMed ID: 34333739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy.
    Roca B; Gómez CJ; Arnedo A
    J Infect; 1999 Sep; 39(2):141-5. PubMed ID: 10609532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.
    Tossonian HK; Raffa JD; Grebely J; Trotter B; Viljoen M; Mead A; Khara M; McLean M; Duncan F; Fraser C; DeVlaming S; Conway B
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):324-7. PubMed ID: 17468668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and Evolution of Antiretroviral Therapy Adherence Among Perinatally HIV-Infected Adolescents in Brazil.
    Côté J; Delmas P; de Menezes Succi RC; Galano E; Auger P; Sylvain H; Colson S; Machado DM
    J Adolesc Health; 2016 Sep; 59(3):305-310. PubMed ID: 27320032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women.
    Simoni JM; Pantalone DW; Plummer MD; Huang B
    Health Psychol; 2007 Jul; 26(4):488-95. PubMed ID: 17605569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive symptoms decline among persons on HIV protease inhibitors.
    Low-Beer S; Chan K; Yip B; Wood E; Montaner JS; O'Shaughnessy MV; Hogg RS
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):295-301. PubMed ID: 10836751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.